Pharmacokinetics and Toxicity of Sodium Selenite in the Treatment of Patients with Carcinoma in a Phase I Clinical Trial: The SECAR Study.
about
Micronutrients in Oncological InterventionRedox-active selenium compounds--from toxicity and cell death to cancer treatmentEffects of Low-dose Selenium on the Inflammatory Response in Coronary Artery Bypass Graft Surgery: A Clinical TrialCombination of carmustine and selenite effectively inhibits tumor growth by targeting androgen receptor, androgen receptor-variants, and Akt in preclinical models: New hope for patients with castration resistant prostate cancer.Selenite promotes all-trans retinoic acid-induced maturation of acute promyelocytic leukemia cells.Dietary Selenium and Human Health.Role of AQP9 in transport of monomethyselenic acid and selenite.Quantification of low molecular weight selenium metabolites in human plasma after treatment with selenite in pharmacological doses by LC-ICP-MS.Application of Sodium Selenite in the Prevention and Treatment of Cancers.Sodium selenite induces apoptosis and inhibits autophagy in human synovial sarcoma cell line SW982 in vitro.The Synergistic Effect of Serine with Selenocompounds on the Expression of SelP and GPx in HepG2 Cells.Selenoprotein P and Selenium Distribution in MammalsSelenium-Related Transcriptional Regulation of Gene Expression
P2860
Q26764839-4CFBDBAC-C906-4FEF-BB1F-52270F03DFFAQ35658137-9B96D781-5C67-42D1-9DBD-32668A70B8B8Q37350664-DF1A2AE5-689A-4480-95A4-FAD4942D33C4Q38769775-5EC4995B-4F5E-413D-A1C4-0558A1B8A915Q41817088-376DD6C4-3DE4-4890-B52D-049AB2789ECDQ42323463-7D67A888-EB56-41C8-BCF3-940D4FBB8489Q46322542-7CD3A5BA-42B7-465F-A509-5799DA3EF413Q47328914-15DD44B0-4B8F-4977-967E-E6688AB73B83Q47422547-A6CF4334-A9E8-4FC9-84D1-DF4AD665154FQ54943194-FF4A4638-452A-4FDC-B1AB-6DE8054C78B0Q55059610-3023C45A-14D1-4D08-B755-522FA03E4D72Q56990444-7E97400D-D783-4460-A69F-01743921D2ACQ58757592-E66795AC-E6D1-45FD-B67A-39553221785B
P2860
Pharmacokinetics and Toxicity of Sodium Selenite in the Treatment of Patients with Carcinoma in a Phase I Clinical Trial: The SECAR Study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Pharmacokinetics and Toxicity ...... inical Trial: The SECAR Study.
@ast
Pharmacokinetics and Toxicity ...... inical Trial: The SECAR Study.
@en
type
label
Pharmacokinetics and Toxicity ...... inical Trial: The SECAR Study.
@ast
Pharmacokinetics and Toxicity ...... inical Trial: The SECAR Study.
@en
prefLabel
Pharmacokinetics and Toxicity ...... inical Trial: The SECAR Study.
@ast
Pharmacokinetics and Toxicity ...... inical Trial: The SECAR Study.
@en
P2093
P2860
P356
P1433
P1476
Pharmacokinetics and Toxicity ...... linical Trial: The SECAR Study
@en
P2093
Charlotte Asker-Hagelberg
Clara Lenneby-Helleday
Dag Mohlkert
Erik H Larsen
Hans Jacobsson
Marita Wallenberg
Mikael Björnstedt
Ola Brodin
Stig Linder
P2860
P304
P356
10.3390/NU7064978
P577
2015-06-19T00:00:00Z